Cargando…
DGM-CM6: A New Model to Predict Distant Recurrence Risk in Operable Endocrine-Responsive Breast Cancer
To investigate the prognostic value of DGM-CM6 (Distant Genetic Model-Clinical variable Model 6) for endocrine-responsive breast cancer (ERBC) patients, we analyzed 752 operable breast cancer patients treated in a Taiwan cancer center from 2005 to 2014. Among them, 490 ERBC patients (identified by t...
Autores principales: | Lei, Lei, Wang, Xiao-Jia, Mo, Yin-Yuan, Cheng, Skye Hung-Chun, Zhou, Yunyun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7263173/ https://www.ncbi.nlm.nih.gov/pubmed/32528885 http://dx.doi.org/10.3389/fonc.2020.00783 |
Ejemplares similares
-
A distinct Golgi-targeting mechanism of dGM130 in Drosophila neurons
por: Cheng, Guo, et al.
Publicado: (2023) -
Gene expression profiling in prognosis of distant recurrence in HR-positive and HER2-negative breast cancer patients
por: Huang, Tzu-Ting, et al.
Publicado: (2018) -
Primary 21-Gene Recurrence Score and Disease Outcome in Loco-Regional and Distant Recurrent Breast Cancer Patients
por: Lu, Yujie, et al.
Publicado: (2020) -
Pattern of Local Recurrence and Distant Metastasis in Breast Cancer By Molecular Subtype
por: Wu, Xingrao, et al.
Publicado: (2016) -
Endocrine-responsive lobular carcinoma of the breast: features associated with risk of late distant recurrence
por: Conforti, Fabio, et al.
Publicado: (2019)